Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 171 M186 M239 M224 M185 M213 M 861 M Research & development —————— — Operating income 1.86 B1.75 B1.84 B943 M2.6 B3.53 B 8.9 B Non-Operating Income, Total -58 M218 M232 M43 M167 M113 M 555 M Interest expense, net of interest capitalized 47 M51 M71 M66 M66 M67 M 270 M Non-Operating Income, excl. Interest Expenses -170 M112 M102 M-56 M78 M8 M 132 M Unusual income/expense 65 M55 M59 M33 M23 M38 M 153 M Pretax income 1.88 B1.75 B1.82 B910 M2.56 B3.5 B 8.79 B Equity in earnings —————— — Taxes 414 M406 M353 M209 M575 M775 M 1.91 B Non-controlling/minority interest —————— — After tax other income/expense -11 M-11 M-2 M-3 M-15 M-2 M -22 M Net income before discontinued operations 1.46 B1.34 B1.47 B701 M1.98 B2.72 B 6.88 B Discontinued operations —————— — Net income 1.46 B1.34 B1.47 B701 M1.98 B2.72 B 6.88 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.46 B1.34 B1.47 B701 M1.98 B2.72 B 6.88 B Basic earnings per share (Basic EPS) 2.662.482.721.313.725.18 12.93 Diluted earnings per share (Diluted EPS) 2.652.462.71.313.75.15 12.86 Average basic shares outstanding 550 M543 M541 M543 M532 M526 M — Diluted shares outstanding 553 M546 M544 M546 M535 M529 M — EBITDA 2.87 B2.8 B3 B2.17 B3.79 B4.79 B 13.75 B EBIT 1.86 B1.75 B1.84 B943 M2.6 B3.53 B 8.9 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.01 B1.05 B1.17 B1.23 B1.19 B1.26 B 4.85 B